D.E. Shaw & Co
ENZY

D.E. Shaw & Co’s Enzymotec Ltd ENZY Stock Holding History

D.E. Shaw & Co’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-35,669
Closed -$268K – 4272
2014
Q4 		$268K Sell
35,669
-250,982
-88% -$1.82M ﹤0.01% 3699
2014
Q3 		$1.92M Sell
286,651
-44,923
-14% -$485K ﹤0.01% 2282
2014
Q2 		$4.5M Buy
331,574
+303,698
+1,089% +$5.1M 0.01% 1699
2014
Q1 		$614K Buy
+27,876
New +$739K ﹤0.01% 3425

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VAM
Visium Asset Management New York $955M AUM 3.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AP
Alydar Partners Boston, Massachusetts $157M AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return